Followers | 51 |
Posts | 1829 |
Boards Moderated | 0 |
Alias Born | 02/12/2022 |
Monday, April 04, 2022 2:56:50 PM
Recent OGEN News
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/11/2024 11:45:36 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 08:45:12 PM
- Oragenics, Inc. Announces Closing of Public Offering • GlobeNewswire Inc. • 09/05/2024 08:30:41 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/05/2024 12:26:02 PM
- Oragenics, Inc. Announces Pricing of Public Offering • GlobeNewswire Inc. • 09/04/2024 12:36:47 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/04/2024 04:15:04 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/03/2024 08:06:54 PM
- Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients • GlobeNewswire Inc. • 08/21/2024 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 12:30:09 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 08/16/2024 08:45:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:30:15 PM
- Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing Standards • GlobeNewswire Inc. • 08/16/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 12:30:38 PM
- Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range • GlobeNewswire Inc. • 08/14/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 12:30:14 PM
- Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study • GlobeNewswire Inc. • 08/12/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 08:30:43 PM
- Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing • GlobeNewswire Inc. • 08/08/2024 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:30:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/22/2024 08:05:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 12:00:30 PM
- Oragenics Improves Intranasal Drug Formulation for Treating Concussed Patients • GlobeNewswire Inc. • 07/10/2024 12:00:00 PM
- Oragenics Develops Automated Intranasal Device for Treating Concussed Patients • GlobeNewswire Inc. • 06/27/2024 12:30:40 PM
- Oragenics, Inc. Announces Closing of Public Offering • GlobeNewswire Inc. • 06/26/2024 08:47:15 PM
- Oragenics, Inc. Announces Pricing of Public Offering • GlobeNewswire Inc. • 06/25/2024 12:30:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM